Showing results (291-300 of 478) with videos related to
Sort By:
Pageof 48
Therapeutic Advances in Gastroenterology|November 24, 2025
A positive Clostridioides difficile test does not impact outcomes in hospitalized patients with acute severe ulcerative colitisGeethanjali Rajagopal, Raghavendra Paknikar, Zifeng Deng, et al.Journal of Crohn'S & Colitis|March 24, 2017
Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled TrialDavid T Rubin, Russell D Cohen, William J Sandborn, et al.Crohn'S & Colitis 360|March 1, 2024
Association Between Smoking Status and the Efficacy and Safety of Tofacitinib in Patients with Ulcerative ColitisDavid T Rubin, Joana Torres, Miguel Regueiro, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 10, 2025
Point-of-Care Ultrasound in Gastroenterology and HepatologyNagasri Shankar, Lily Kuo, Noa Krugliak Cleveland, et al.Journal of Crohn'S & Colitis|March 19, 2023
Transient Suppression of Bacterial Populations Associated with Gut Health is Critical in Success of Exclusive Enteral Nutrition for Children with Crohn's DiseaseJoseph Runde, Iva Veseli, Emily C Fogarty, et al.Crohn'S & Colitis 360|June 22, 2026
Dual-targeted therapy with risankizumab and upadacitinib in medically complex Crohn's diseaseEvan N Fear, Benjamin D McDonald, Megan S Kennedy, et al.Therapeutic Advances in Gastroenterology|May 26, 2021
Extraintestinal manifestations at baseline, and the effect of tofacitinib, in patients with moderate to severe ulcerative colitisDavid T Rubin, Walter Reinisch, Thomas Greuter, et al.United European Gastroenterology Journal|May 5, 2021
Ustekinumab is more effective than azathioprine to prevent endoscopic postoperative recurrence in Crohn's diseaseAnthony Buisson, Stéphane Nancey, Luc Manlay, et al.Digestive Diseases and Sciences|February 8, 2012
Assessment of variables associated with smoking cessation in Crohn's diseaseYvette Leung, Gil G Kaplan, Kevin P Rioux, et al.The American Journal of Gastroenterology|June 9, 2026
Impact of Upadacitinib on Cardiovascular Events and Lipid Values in Older Inflammatory Bowel Disease Patients with Baseline Cardiovascular RiskTenzin Choden, Alex J Mathew, Aaron Goffinet, et al.Pageof 48